Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955214382> ?p ?o ?g. }
- W2955214382 endingPage "6893" @default.
- W2955214382 startingPage "6876" @default.
- W2955214382 abstract "The hypoxia-inducible factor 2α (HIF-2α) is a key oncogenic driver in clear cell renal cell carcinoma (ccRCC). Our first HIF-2α inhibitor PT2385 demonstrated promising proof of concept clinical activity in heavily pretreated advanced ccRCC patients. However, PT2385 was restricted by variable and dose-limited pharmacokinetics resulting from extensive metabolism of PT2385 to its glucuronide metabolite. Herein we describe the discovery of second-generation HIF-2α inhibitor PT2977 with increased potency and improved pharmacokinetic profile achieved by reduction of phase 2 metabolism. Structural modification by changing the geminal difluoro group in PT2385 to a vicinal difluoro group resulted in enhanced potency, decreased lipophilicity, and significantly improved pharmacokinetic properties. In a phase 1 dose-escalation study, the clinical pharmacokinetics for PT2977 supports the hypothesis that attenuating the rate of glucuronidation would improve exposure and reduce variability in patients. Early evidence of clinical activity shows promise for PT2977 in the treatment of ccRCC." @default.
- W2955214382 created "2019-07-12" @default.
- W2955214382 creator A5002561348 @default.
- W2955214382 creator A5006480894 @default.
- W2955214382 creator A5018250249 @default.
- W2955214382 creator A5018935468 @default.
- W2955214382 creator A5026746688 @default.
- W2955214382 creator A5044970684 @default.
- W2955214382 creator A5045945306 @default.
- W2955214382 creator A5046084136 @default.
- W2955214382 creator A5053460406 @default.
- W2955214382 creator A5056879450 @default.
- W2955214382 creator A5060416015 @default.
- W2955214382 creator A5062856863 @default.
- W2955214382 creator A5077952151 @default.
- W2955214382 creator A5078188996 @default.
- W2955214382 creator A5081064903 @default.
- W2955214382 creator A5081153209 @default.
- W2955214382 creator A5081675192 @default.
- W2955214382 creator A5086713553 @default.
- W2955214382 creator A5089942308 @default.
- W2955214382 date "2019-06-24" @default.
- W2955214382 modified "2023-10-16" @default.
- W2955214382 title "3-[(1<i>S</i>,2<i>S</i>,3<i>R</i>)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma" @default.
- W2955214382 cites W1498305210 @default.
- W2955214382 cites W1976859506 @default.
- W2955214382 cites W1988377666 @default.
- W2955214382 cites W1990094979 @default.
- W2955214382 cites W1998664010 @default.
- W2955214382 cites W2012131946 @default.
- W2955214382 cites W2020021293 @default.
- W2955214382 cites W2020344223 @default.
- W2955214382 cites W2022451432 @default.
- W2955214382 cites W2040611122 @default.
- W2955214382 cites W2042216712 @default.
- W2955214382 cites W2042702043 @default.
- W2955214382 cites W2063915017 @default.
- W2955214382 cites W2081460564 @default.
- W2955214382 cites W2082886132 @default.
- W2955214382 cites W2085609942 @default.
- W2955214382 cites W2087019997 @default.
- W2955214382 cites W2094242056 @default.
- W2955214382 cites W2094518946 @default.
- W2955214382 cites W2094779541 @default.
- W2955214382 cites W2096172976 @default.
- W2955214382 cites W2102476325 @default.
- W2955214382 cites W2129621205 @default.
- W2955214382 cites W2135705997 @default.
- W2955214382 cites W2136875815 @default.
- W2955214382 cites W2137028606 @default.
- W2955214382 cites W2142719287 @default.
- W2955214382 cites W2144625075 @default.
- W2955214382 cites W2159091117 @default.
- W2955214382 cites W2164210517 @default.
- W2955214382 cites W2165466452 @default.
- W2955214382 cites W2167845320 @default.
- W2955214382 cites W2203399572 @default.
- W2955214382 cites W2264719596 @default.
- W2955214382 cites W2336905409 @default.
- W2955214382 cites W2510079645 @default.
- W2955214382 cites W2513249090 @default.
- W2955214382 cites W2514212469 @default.
- W2955214382 cites W2551559191 @default.
- W2955214382 cites W2614480329 @default.
- W2955214382 cites W2778771081 @default.
- W2955214382 cites W2785609333 @default.
- W2955214382 cites W2794990556 @default.
- W2955214382 cites W2807988274 @default.
- W2955214382 cites W2887505080 @default.
- W2955214382 cites W2891140245 @default.
- W2955214382 cites W2895634053 @default.
- W2955214382 cites W2977883209 @default.
- W2955214382 cites W4211262396 @default.
- W2955214382 cites W4214771208 @default.
- W2955214382 doi "https://doi.org/10.1021/acs.jmedchem.9b00719" @default.
- W2955214382 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31282155" @default.
- W2955214382 hasPublicationYear "2019" @default.
- W2955214382 type Work @default.
- W2955214382 sameAs 2955214382 @default.
- W2955214382 citedByCount "113" @default.
- W2955214382 countsByYear W29552143822019 @default.
- W2955214382 countsByYear W29552143822020 @default.
- W2955214382 countsByYear W29552143822021 @default.
- W2955214382 countsByYear W29552143822022 @default.
- W2955214382 countsByYear W29552143822023 @default.
- W2955214382 crossrefType "journal-article" @default.
- W2955214382 hasAuthorship W2955214382A5002561348 @default.
- W2955214382 hasAuthorship W2955214382A5006480894 @default.
- W2955214382 hasAuthorship W2955214382A5018250249 @default.
- W2955214382 hasAuthorship W2955214382A5018935468 @default.
- W2955214382 hasAuthorship W2955214382A5026746688 @default.
- W2955214382 hasAuthorship W2955214382A5044970684 @default.
- W2955214382 hasAuthorship W2955214382A5045945306 @default.
- W2955214382 hasAuthorship W2955214382A5046084136 @default.
- W2955214382 hasAuthorship W2955214382A5053460406 @default.
- W2955214382 hasAuthorship W2955214382A5056879450 @default.
- W2955214382 hasAuthorship W2955214382A5060416015 @default.
- W2955214382 hasAuthorship W2955214382A5062856863 @default.